7 withdrawn, 4 unknown, 1 completed. 12 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Withdrawn 7, Unknown 4, Completed 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Complementary Therapies: new trials by email Literature Review of Complementary Therapies trials Research Report on Complementary Therapies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chinese Medicine on Deferring Dialysis Initiation CM therapies, CKD-related management - End-Stage Renal Disease | Phase 1 / Phase 2 | Unknown | Guangdong Provincial Hospital of Traditional Chinese Medicine | 875 | 2014-07-01 | 2019-12-26 |
| Relationship Between Treatment With Bach´s Flower Remedy and Spiritual Well-Being of People With Common Mental Disorder Bach´s Flower Remedy, Placebo group - Mental Disorders, Personal Well Being | Phase 2 | Completed | UPECLIN HC FM Botucatu Unesp | 70 | 2011-02-01 | 2012-01-18 |
| Improving Hand Use in Multiple Sclerosis CI Therapy, CAM treatments - Multiple Sclerosis | Phase 2 | Unknown | National Multiple Sclerosis Society | 66 | 2010-02-01 | 2015-04-15 |
| Removal of Endotracheal Tube Secretions Comprehensively Until Extubation CAM (Complete Airway Management) Catheters - Mechanical Ventilation, Pneumonia | Phase 2 | Unknown | O. M. Neotech, Inc. | 30 | 2008-04-01 | 2008-05-29 |
| Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer paclitaxel, oxaliplatin, leucovorin - Adenocarincoma of Pancreas, Stage III Pancreatic Cancer | Phase 2 | Unknown | Seattle Cancer Treatment and Wellness Center | 80 | 2006-05-01 | 2007-05-08 |
| Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer antineoplaston A10, antineoplaston AS2-1, bicalutamide - Adenocarcinoma of the Prostate, Stage III Prostate Cancer | Phase 2 | Withdrawn | Burzynski Research Institute | 2013-07-10 | ||
| Antineoplaston Therapy in Treating Women With Advanced Breast Cancer antineoplaston A10, antineoplaston AS2-1, alternative product therapy - Stage IV Breast Cancer, Recurrent Breast Cancer | Phase 2 | Withdrawn | Burzynski Research Institute | 2013-07-10 | ||
| Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma antineoplaston A10, antineoplaston AS2-1, alternative product therapy - Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma | Phase 2 | Withdrawn | Burzynski Research Institute | 2013-07-10 | ||
| Antineoplaston Therapy in Treating Patients With Colon Cancer antineoplaston A10, antineoplaston AS2-1, alternative product therapy - Stage IV Colon Cancer, Recurrent Colon Cancer | Phase 2 | Withdrawn | Burzynski Research Institute | 2013-07-10 | ||
| Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy antineoplaston A10, antineoplaston AS2-1, alternative product therapy - Merkel Cell Carcinoma, Islet Cell Carcinoma | Phase 2 | Withdrawn | Burzynski Research Institute | 2013-07-10 | ||
| Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer antineoplaston A10, methotrexate, alternative product therapy - Stage IV Breast Cancer, Recurrent Breast Cancer | Phase 2 | Withdrawn | Burzynski Research Institute | 2013-07-10 | ||
| Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma antineoplaston A10, antineoplaston AS2-1, alternative product therapy - Primary Central Nervous System Lymphoma | Phase 2 | Withdrawn | Burzynski Research Institute | 2013-07-10 |
Breast Neoplasms (2) · Bites and Stings (1) · Carcinoma, Islet Cell (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Neuroendocrine (1) · Colonic Neoplasms (1) · Growth Hormone-Secreting Pituitary Adenoma (1) · Kidney Failure, Chronic (1) · Lymphoma, Mantle-Cell (1) · Mental Disorders (1) · Motor Activity (1) · Multiple Sclerosis (1) · Neoplasms (1) · Pancreatic Neoplasms (1) · Pituitary Neoplasms (1)
Burzynski Research Institute (7) · Guangdong Provincial Hospital of Traditional Chinese Medicine (1) · National Multiple Sclerosis Society (1) · O. M. Neotech, Inc. (1) · Seattle Cancer Treatment and Wellness Center (1) · UPECLIN HC FM Botucatu Unesp (1)
United States (10) · Brazil (1) · China (1)
Stanislaw R. Burzynski, MD, PhD (7) · Ben Chue, MD (1) · Ivan A Guerrini, PhD (1) · Orlando V. Morejon, MD (1) · Ping Li, PhD (1) · Ruth Turrini, PhD (1) · Victor W Mark, MD (1) · Xusheng Liu, MD (1)